BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

957 related articles for article (PubMed ID: 2884804)

  • 1. Prejunctional adrenergic receptors and sympathetic neurotransmission: studies in canine skeletal muscle vasculature in situ.
    Kahan T
    Acta Physiol Scand Suppl; 1987; 560():1-38. PubMed ID: 2884804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta2-adrenoceptor-mediated prejunctional facilitation and postjunctional inhibition of sympathetic neuroeffector transmission in the guinea pig vas deferens.
    Todorov LD; Clerkin R; Mihaylova-Todorova ST; Khoyi MA; Westfall DP
    J Pharmacol Exp Ther; 2001 Aug; 298(2):623-33. PubMed ID: 11454924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prejunctional beta 2-adrenoreceptor blockade reduces nerve stimulation evoked release of endogenous noradrenaline in skeletal muscle in situ.
    Dahlöf C; Kahan T; Ablad B
    Acta Physiol Scand; 1987 Apr; 129(4):499-503. PubMed ID: 2884805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of angiotensin II, alpha- and beta-adrenoceptors on peripheral noradrenergic neurotransmission in canine gracilis muscle in vivo.
    Schwieler JH; Kahan T; Nussberger J; Johansson MC; Hjemdahl P
    Acta Physiol Scand; 1992 Aug; 145(4):333-43. PubMed ID: 1326853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prejunctional beta 2-adrenoceptor-mediated enhancement of noradrenaline release in skeletal muscle vasculature in situ.
    Kahan T; Hjemdahl P
    J Cardiovasc Pharmacol; 1987 Oct; 10(4):433-8. PubMed ID: 2444796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible involvement of neuropeptide Y in sympathetic vascular control of canine skeletal muscle.
    Pernow J; Kahan T; Hjemdahl P; Lundberg JM
    Acta Physiol Scand; 1988 Jan; 132(1):43-50. PubMed ID: 2906210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between the overflow of endogenous and radiolabelled noradrenaline from canine blood perfused gracilis muscle.
    Kahan T; Hjemdahl P; Dahlöf C
    Acta Physiol Scand; 1984 Dec; 122(4):571-82. PubMed ID: 6098140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-adrenergic, non-cholinergic vascular control with reference to neuropeptide Y, vasoactive intestinal polypeptide and nitric oxide.
    Modin A
    Acta Physiol Scand Suppl; 1994; 622():1-74. PubMed ID: 7524267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-release and functional interactions of neuropeptide Y and noradrenaline in peripheral sympathetic vascular control.
    Pernow J
    Acta Physiol Scand Suppl; 1988; 568():1-56. PubMed ID: 3232527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noradrenaline release evoked by a physiological irregular sympathetic discharge pattern is modulated by prejunctional alpha- and beta-adrenoceptors in vivo.
    Kahan T; Pernow J; Schwieler J; Wallin BG; Lundberg JM; Hjemdahl P
    Br J Pharmacol; 1988 Dec; 95(4):1101-8. PubMed ID: 2851357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adrenergic and non-adrenergic mechanisms in sympathetic vascular control of the nasal mucosa.
    Lacroix JS
    Acta Physiol Scand Suppl; 1989; 581():1-63. PubMed ID: 2568728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Additional evidence for functional subclassification of alpha-2 adrenoceptors based on a new selective antagonist, SK&F 104856.
    Hieble JP; Sulpizio AC; Edwards R; Chapman H; Young P; Roberts SP; Blackburn TP; Wood MD; Shah DH; Demarinis RM
    J Pharmacol Exp Ther; 1991 Nov; 259(2):643-52. PubMed ID: 1682482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prejunctional alpha-adrenoceptor-mediated inhibition of norepinephrine release in blood-perfused skeletal muscle in situ.
    Kahan T; Dahlöf C; Hjemdahl P
    J Cardiovasc Pharmacol; 1987 May; 9(5):555-62. PubMed ID: 2439837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presynaptic regulation of the release of catecholamines.
    Langer SZ
    Pharmacol Rev; 1980 Dec; 32(4):337-62. PubMed ID: 6267618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presynaptic alpha2-adrenoceptor-mediated modulation of adenosine 5' triphosphate and noradrenaline corelease: differences in canine mesenteric artery and vein.
    Bobalova J; Mutafova-Yambolieva VN
    J Auton Pharmacol; 2001 Feb; 21(1):47-55. PubMed ID: 11422578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurogenic cholinergic prejunctional inhibition of sympathetic beta adrenergic relaxation in the canine coronary artery.
    Cohen RA; Shepherd JT; Vanhoutte PM
    J Pharmacol Exp Ther; 1984 May; 229(2):417-21. PubMed ID: 6325664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of antihypertensive drugs on sympathetic vascular control in relation to neuropeptide Y.
    Lundberg JM; Pernow J; Franco-Cereceda A; Rudehill A
    J Cardiovasc Pharmacol; 1987; 10 Suppl 12():S51-68. PubMed ID: 2455193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Release and vasoconstrictor effects of neuropeptide Y in relation to non-adrenergic sympathetic control of renal blood flow in the pig.
    Pernow J; Lundberg JM
    Acta Physiol Scand; 1989 Aug; 136(4):507-17. PubMed ID: 2571235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Participation of prostaglandins and bradykinin in the effects of angiotensin II and converting enzyme-inhibition on sympathetic neurotransmission in vivo.
    Schwieler JH; Kahan T; Nussberger J; Hjemdahl P
    Acta Physiol Scand; 1994 Sep; 152(1):83-91. PubMed ID: 7810335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre- and postjunctional alpha-adrenoceptor-mediated effects of prazosin, methoxamine and 6-fluoronoradrenaline in blood-perfused canine skeletal muscle in situ.
    Kahan T; Hjemdahl P
    Eur J Pharmacol; 1987 Jan; 133(1):9-20. PubMed ID: 3030774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 48.